Nextcure to present at the ladenburg thalmann healthcare conference

Beltsville, md., sept. 22, 2022 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the ladenburg thalmann healthcare conference in new york city on thursday, september 29th at 10 am et.
NXTC Ratings Summary
NXTC Quant Ranking